Clinical Trial: Efficacy and Safety of Vascepa (icosapent ethyl) Combined with Diverse Dyslipidemia Treatment Regimens in Patients with Severe Hypertriglyceridemia: A Prospective Cohort Study. (China)

Posted On: 2026-10-16

China, Oct. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Vascepa (icosapent ethyl) Combined with Diverse Dyslipidemia Treatment Regimens in Patients with Severe Hypertriglyceridemia: A Prospective Cohort Study.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134497

Registration Time: 2026/10/15

Type: Observational study

Primary Sponsor: Shanghai General Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=308392

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Efficacy and Safety of Vascepa (icosapent ethyl) Combined with Diverse Dyslipidemia Treatment Regimens in Patients with Severe Hypertriglyceridemia: A Prospective Cohort Study. (China)